Scambia G - Search Results

1

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial.

Coleman RL, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp A, Scambia G, Leary A, Holloway RW, Gancedo MA, Fong PC, Goh JC, O'Malley DM, Armstrong DK, Garcia-Donas J, Swisher EM, Floquet A, Konecny GE, McNeish IA, Scott CL, Cameron T, Maloney L, Isaacson J, Goble S, Grace C, Harding TC, Raponi M, Sun J, Lin KK, Giordano H, Ledermann JA; ARIEL3 investigators. Coleman RL, et al. Among authors: scambia g. Lancet. 2017 Oct 28;390(10106):1949-1961. doi: 10.1016/S0140-6736(17)32440-6. Epub 2017 Sep 12. Lancet. 2017. PMID: 28916367 Free PMC article. Clinical Trial.

2

Phase I study of gemcitabine and liposomal doxorubicin in relapsed ovarian cancer.

D'Agostino G, Ferrandina G, Garganese G, Salerno MG, Lorusso D, Farnetano MG, Mancuso S, Scambia G. D'Agostino G, et al. Among authors: scambia g. Oncology. 2002;62(2):110-4. doi: 10.1159/000048255. Oncology. 2002. PMID: 11914595 Clinical Trial.

3

Phase II study of gemcitabine in recurrent platinum-and paclitaxel-resistant ovarian cancer.

D'Agostino G, Amant F, Berteloot P, Scambia G, Vergote I. D'Agostino G, et al. Among authors: scambia g. Gynecol Oncol. 2003 Mar;88(3):266-9. doi: 10.1016/s0090-8258(03)00011-8. Gynecol Oncol. 2003. PMID: 12648573 Clinical Trial.

4

The role of chemotherapy in locally advanced, metastatic and recurrent cervical cancer.

Tambaro R, Scambia G, Di Maio M, Pisano C, Barletta E, Iaffaioli VR, Pignata S. Tambaro R, et al. Among authors: scambia g. Crit Rev Oncol Hematol. 2004 Oct;52(1):33-44. doi: 10.1016/j.critrevonc.2004.05.003. Crit Rev Oncol Hematol. 2004. PMID: 15363465 Review.

5

Gemcitabine and liposomal doxorubicin in the salvage treatment of ovarian cancer: updated results and long-term survival.

Ferrandina G, Paris I, Ludovisi M, D'Agostino G, Testa A, Lorusso D, Zanghi M, Pisconti S, Pezzella G, Adamo V, Breda E, Scambia G. Ferrandina G, et al. Among authors: scambia g. Gynecol Oncol. 2005 Aug;98(2):267-73. doi: 10.1016/j.ygyno.2005.04.018. Gynecol Oncol. 2005. PMID: 15975643 Clinical Trial.

6

Increased cyclooxygenase-2 expression is associated with better clinical outcome in patients submitted to complete ablation for severe endometriosis.

Fanfani F, Fagotti A, Ferrandina G, Bifulco G, Legge F, Lorusso D, Minelli L, Scambia G. Fanfani F, et al. Among authors: scambia g. Hum Reprod. 2005 Oct;20(10):2964-8. doi: 10.1093/humrep/dei160. Epub 2005 Jun 24. Hum Reprod. 2005. PMID: 15979990

7

Advanced vulvar carcinoma: is it worth operating? A perioperative management protocol for radical and reconstructive surgery.

Fanfani F, Garganese G, Fagotti A, Lorusso D, Gagliardi ML, Rossi M, Salgarello M, Scambia G. Fanfani F, et al. Among authors: scambia g. Gynecol Oncol. 2006 Nov;103(2):467-72. doi: 10.1016/j.ygyno.2006.03.022. Epub 2006 May 2. Gynecol Oncol. 2006. PMID: 16647747

8

Anemia in patients with locally advanced cervical carcinoma administered preoperative radiochemotherapy: association with pathological response to treatment and clinical outcome.

Ferrandina G, Distefano M, Smaniotto D, Morganti A, Paglia A, Macchia G, Corvari B, Lorusso D, Scambia G. Ferrandina G, et al. Among authors: scambia g. Gynecol Oncol. 2006 Nov;103(2):500-5. doi: 10.1016/j.ygyno.2006.03.039. Epub 2006 May 4. Gynecol Oncol. 2006. PMID: 16677692

9

Investigational agents against platinum-resistant ovarian cancer.

Lorusso D, Ferrandina G, Fanfani F, Gagliardi ML, Scambia G. Lorusso D, et al. Among authors: scambia g. Expert Opin Investig Drugs. 2007 Mar;16(3):325-36. doi: 10.1517/13543784.16.3.325. Expert Opin Investig Drugs. 2007. PMID: 17302527 Review.

10

A phase II study of weekly carboplatin and paclitaxel as first-line treatment of elderly patients with advanced ovarian cancer. A Multicentre Italian Trial in Ovarian cancer (MITO-5) study.

Pignata S, Breda E, Scambia G, Pisano C, Zagonel V, Lorusso D, Greggi S, De Vivo R, Ferrandina G, Gallo C, Perrone F. Pignata S, et al. Among authors: scambia g. Crit Rev Oncol Hematol. 2008 Jun;66(3):229-36. doi: 10.1016/j.critrevonc.2007.12.005. Epub 2008 Feb 1. Crit Rev Oncol Hematol. 2008. PMID: 18243011 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,968 results

Search Page